Sichenzia Ross Ference LLP Represents BriaCell Therapeutics Corp. in $27.2 Million Private Placement

Press Release – New York, New York – June 8, 2021 – Sichenzia Ross Ference LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, in a private placement offering. The offering consisted of (i) 4,370,343 common shares at a purchase price of US$5.26, (ii) 800,000 pre-funded common share purchase warrants at a purchase price of US$5.25 (exercisable at any time after the date of issuance at an exercise price of US$0.01 per common share) and (iii) 5,170,343 warrants to purchase up to 5,170,343 common shares. The gross proceeds were approximately $27.2 million.

ThinkEquity, a division of Fordham Financial Management, Inc., acted as the exclusive placement agent for the offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Avital Perlman, Arthur Marcus, Marcelle Balcombe and law clerk Zachary Weiss.

Author
Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $6.87 Million Public Offering of Common Stock of Twin Vee PowerCats Co. - October 4, 2022
Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $5.75 Million Public Offering and Nasdaq Uplisting of Silo Pharma, Inc. - October 1, 2022
Mid-Level Corporate Associate - September 29, 2022

Sichenzia Ross Ference LLP Represents BriaCell Therapeutics Corp. in $27.2 Million Private Placement

Related Posts